Copyright
©2012 Baishideng Publishing Group Co.
World J Gastroenterol. Apr 28, 2012; 18(16): 1915-1920
Published online Apr 28, 2012. doi: 10.3748/wjg.v18.i16.1915
Published online Apr 28, 2012. doi: 10.3748/wjg.v18.i16.1915
Univariate analysis | Multivariate analysis | ||
DSS | OS | OS | |
Neoadjuvant group | |||
Caspase-cleaved CK-18 positivity | 0.975 | 0.865 | 1.32 |
TRG 1-3 vs 4-5 | 0.038 | 0.136 | 0.109 |
Tumour diff. (well/mod vs poor) | 0.087 | 0.101 | 0.32 |
T stage (T1, 2 and 3, 4) | 0.07 | 0.09 | 0.101 |
N stage (N0 and > N1) | 0.106 | 0.124 | 0.23 |
M stage (M0 and > M0) | 0.23 | 0.14 | 1.72 |
Vascular invasion | 0.87 | 0.76 | 0.86 |
Perineural invasion | 1.32 | 1.455 | 1.76 |
Resection margin involvement | 2.34 | 1.98 | 0.24 |
Surgery only group | |||
Caspase-cleaved CK-18 positivity | 0.003 | 0.668 | 0.10 |
TRG 1-3 vs 4-5 | 0.87 | 0.003 | 0.23 |
Tumour diff. (well/mod vs poor) | 0.39 | 0.34 | 0.21 |
T stage (T1, 2 and 3, 4) | 0.04 | 0.08 | 0.19 |
N stage (N0 and > N1) | 0.16 | 0.10 | 0.43 |
M stage (M0 and > M0) | 1.27 | 1.64 | 1.99 |
Vascular invasion | 1.98 | 1.67 | 1.34 |
Perineural invasion | 1.56 | 1.99 | 2.43 |
Resection margin involvement | 0.34 | 0.25 | 0.34 |
- Citation: Fareed KR, Soomro IN, Hameed K, Arora A, Lobo DN, Parsons SL, Madhusudan S. Caspase-cleaved cytokeratin-18 and tumour regression in gastro-oesophageal adenocarcinomas treated with neoadjuvant chemotherapy. World J Gastroenterol 2012; 18(16): 1915-1920
- URL: https://www.wjgnet.com/1007-9327/full/v18/i16/1915.htm
- DOI: https://dx.doi.org/10.3748/wjg.v18.i16.1915